Skip to content
healthcare.dev

EGATEN

NDC 0078-0937, triclabendazole, tablet, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0937
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208711
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0937 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRICLABENDAZOLE250 mg/1

Pharmacologic classes

Anthelmintic [EPC]; Anthelmintics [CS]; Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2A6 Inhibitors [MoA]; Cytochrome P450 2B6 Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]

Package NDCNDC-11Package
0078-0937-91000780937914 TABLET in 1 BLISTER PACK (0078-0937-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5552884e-10ea-450c-9658-d3d4f33c946e

Use it

Look up 0078-0937 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0937 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0937. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.